Clinical Trials

Clinical Trials Underway at CSU

A great deal of test data and anecdotal evidence indicates that cannabinoids provide animals with symptomatic relief from a range of medical conditions. Specifically, the most recent report, http://nationalacademies.org/hmd/reports/2017/health-effects-of-cannabis-and-cannabinoids.aspx addressed many issues in great detail. However, none of the products currently on the market has been studied under the standards required by regulatory authorities like the Food and Drug Administration (“FDA”), proving that they are safe and effective. Therefore, ABSC is conducting groundbreaking clinical trials at CSU.

ABSC has completed a Phase 1 study to investigate the safety of specified combinations of CHO and delivery methods in dogs. The study confirmed that the dogs tolerated the clinical dosages very well, and the study results were presented at the Institute of Cannibis Research Conference at CSU-Pueblo on April 29, 2017.

ABSC’s Phase 2 clinical trials have begun, October 2016, and will study the efficacy of CHO in the treatment of selected medical conditions. The specific medical conditions include:

  • Osteoarthritis and chronic pain

  • Epilepsy and seizure disorders

Disclaimer

This product has been tested as safe.  However, every dog, breed and situation is different.  Please consult with your veterinarian in order to make an informed decision, discuss any complications and report any adverse side effects. Until we complete our clinical trials we cannot recommend our product for the diagnosis, prevention, treatment or cure of any disease or ailment.

Music

“Home We'll Go”
Written by Sarah Blackwood, Ryan Marshall, Gianni Luminati and Thomas Salter
Performed by Walk Off The Earth
Courtesy of Columbia Records
By arrangement with Sony Music Licensing
FROM THE MOTION PICTURE: A DOG'S PURPOSE
AN AMBLIN AND WALDEN MEDIA PRODUCTION, A UNIVERSAL RELEASE